HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

Tirzepatide cut progression from prediabetes to diabetes by over 90%

Gokhan Can · Sep 03, 2024 · ♥ 4 reactions · 4 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)Insulin resistance & diabetes
AI summary & key facts

Gokhan notes that tirzepatide (a GLP-1/GIP drug) cut the chance of progressing from prediabetes to diabetes by over 90%, linking a ScienceAlert report of a 94% reduction in adults with obesity or overweight and prediabetes.

Tirzepatide (GLP1 plus GIP drug) cut the chances of transitioning from pre-diabetes to diabetes by over 90%.

ScienceAlertWeight Loss Drug Reduces Diabetes Risk by 94 Percent in Clinical TrialTirzepatide, the active ingredient in the popular weight loss drug Zepbound, has been shown to reduce the risk of developing type 2 diabetes in obese or overweight adults with pre-diabetes by a huge 94 percent.sciencealert.com

Research cited

#diabetes#prediabetes#glp1
← newer: Review: nuts, olive oil and nutraceuticals can lower small dolder: How to eat for a long, healthy life: NYT guidance summarized →